Approval · Notice of Compliance 3137 · 1998
PROLEUKIN: Notice of Compliance 3137
Issued December 10, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3137
- Date
- December 10, 1998
- Company
- Chiron Corporation
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: treatment of patients with metatstic malignant melanoma
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROLEUKIN | Not yet assigned | — |
Medicinal ingredients
- ALDESLEUKIN 22,000,000 UNIT per VIAL